Published in:
Open Access
01-02-2011 | Poster presentation
Dexmedetomidine improves attention and recall in agitated critically ill patients
Authors:
MM Mirski, RG Gill, PM Murakami, CT Thompson, JL Lewin
Published in:
Critical Care
|
Special Issue 1/2011
Login to get access
Excerpt
It is of clinical interest to maintain patient comfort in the ICU and yet preserve their intellectual function, arousal and interaction. Recently, dexmedetomidine (DEX) was demonstrated in the ANIST Trial to preserve intellectual function as compared with propofol (PRO) when used as conscious sedation in both agitated neurologically intact and brain-injured critically ill patients [
1]. The purpose of this study was to further understand whether selective areas of cognition were specifically affected by PRO and DEX through sub-analysis of the Trial's results on each of the five subscales of the Adapted Cognitive Exam (ACE). …